206 related articles for article (PubMed ID: 28317305)
1. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I
Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305
[No Abstract] [Full Text] [Related]
2. Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Beiras-Fernandez A; Bigdeli AK; Nickel T; Michel S; Ueberfuhr P; Reichart B; Kaczmarek I
Exp Clin Transplant; 2011 Aug; 9(4):279-83. PubMed ID: 21819376
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient.
Yoshida H; Seki M; Umeyama T; Urai M; Kinjo Y; Nishi I; Toyokawa M; Kaneko Y; Ohno H; Miyazaki Y; Tomono K
J Infect Chemother; 2015 Jun; 21(6):479-81. PubMed ID: 25828927
[TBL] [Abstract][Full Text] [Related]
4. Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient.
Wadi J; Al-kawasmeh SI; Kamel MT; AlJayyousi BB
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):914-8. PubMed ID: 20814131
[TBL] [Abstract][Full Text] [Related]
5. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
[TBL] [Abstract][Full Text] [Related]
6. Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus.
Jeurissen A; Cooreman S; Van Kerckhoven W; Van Leemput J; Vanhove P; Lagrou K; Heytens L
Acta Clin Belg; 2012; 67(1):46-8. PubMed ID: 22480040
[TBL] [Abstract][Full Text] [Related]
7. Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Kontoyiannis DP; Ratanatharathorn V; Young JA; Raymond J; Laverdière M; Denning DW; Patterson TF; Facklam D; Kovanda L; Arnold L; Lau W; Buell D; Marr KA
Transpl Infect Dis; 2009 Feb; 11(1):89-93. PubMed ID: 18983417
[TBL] [Abstract][Full Text] [Related]
8. Micafungin for the treatment of invasive aspergillosis.
Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA
J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
10. [Case of chronic necrotizing pulmonary aspergillosis complicated by elevated eosinophils and serum IgE].
Morita H; Oguri T; Uemura T; Iwashima Y; Nakamura A; Sato S
Nihon Kokyuki Gakkai Zasshi; 2010 Nov; 48(11):842-6. PubMed ID: 21141064
[TBL] [Abstract][Full Text] [Related]
11. [Deep-seated mycosis. Aspergillus lentulus].
Yaguchi T
Med Mycol J; 2015; 56(4):J137-8. PubMed ID: 26617110
[No Abstract] [Full Text] [Related]
12. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
13. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
[TBL] [Abstract][Full Text] [Related]
14. Treatment of drug-resistant Aspergillus infection.
Aigner M; Lass-Flörl C
Expert Opin Pharmacother; 2015; 16(15):2267-70. PubMed ID: 26328502
[TBL] [Abstract][Full Text] [Related]
15. Echinocandin activity against Aspergillus spp. and the importance of pharmacodynamics.
Lewis JS
Med Mycol; 2009; 47 Suppl 1():S376-81. PubMed ID: 19296368
[TBL] [Abstract][Full Text] [Related]
16. [Azole-resistant invasive aspergillosis].
van der Linden JW; Warris A; van der Meer JW; Bresters D; Melchers WJ; Verweij PE
Ned Tijdschr Geneeskd; 2009; 153():A765. PubMed ID: 20051169
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
Madureira A; Bergeron A; Lacroix C; Robin M; Rocha V; de Latour RP; Ferry C; Devergie A; Lapalu J; Gluckmana E; Socié G; Ghannoum M; Ribaud P
Int J Antimicrob Agents; 2007 Dec; 30(6):551-4. PubMed ID: 18029149
[TBL] [Abstract][Full Text] [Related]
19. Fatal outcome after heart transplantation caused by Aspergillus lentulus.
Zbinden A; Imhof A; Wilhelm MJ; Ruschitzka F; Wild P; Bloemberg GV; Mueller NJ
Transpl Infect Dis; 2012 Oct; 14(5):E60-3. PubMed ID: 22988985
[TBL] [Abstract][Full Text] [Related]
20. Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Yu J; Mu X; Li R
J Clin Microbiol; 2013 Apr; 51(4):1327-9. PubMed ID: 23363828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
